The global small animal imaging (in vivo) market was estimated to be US $ 1.61 billion in 2016. It is expected to rise at a CAGR of 9.0% during the forecast period. The growing demand for non-invasive methods will drive the global small animal imaging market. This technology offers great advantages for conducting research without significant harm to animals and their physiology. Animals can continue their normal life without being affected by research. In contrast to tests based on tissue or cell culture, studies in intact animals incorporate interrelated biological factors that are present in complex organisms. Increased investment in clinical research institutes for preclinical research applications such as post-dose drug efficacy monitoring, epigenetics, and cancer cell detection will boost the size of the small animal imaging market during the forecast period.
A full report of Small Animal Imaging Market available at: https://www.orionmarketreports.com/small-animal-imaging-market/22836/
Small Animal Imaging Market- Segmentation
By Technology
• Micro-Magnetic Resonance Imaging (Micro-MRI)
• Optical Imaging (OI)
• Nuclear Imaging
• Others
By Applications
• Monitoring Drug Treatment Response
• Biodistribution Studies
• Cancer Cell Detection
• Biomarkers
• Longitudinal Studies
• Epigenetics
Company Profiles
• PerkinElmer, Inc.
• Bruker Corporation
• Fujifilm Holdings Corporation
• Medisco Ltd.
• Milabs B.V.
• MR Solutions Ltd.
• Aspect Imaging Ltd.
• Li-Cor Biosciences
• Trifoil Imaging
• Miltenyi Biotech GmbH
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
